Kiran Kumar Solingapuram Sai
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Positron-Emission Tomography | 14 | 2024 | 163 | 3.710 |
Why?
|
| Radiopharmaceuticals | 9 | 2024 | 93 | 2.380 |
Why?
|
| Glioblastoma | 5 | 2017 | 156 | 1.770 |
Why?
|
| Brain | 9 | 2024 | 951 | 1.460 |
Why?
|
| Fluorine Radioisotopes | 4 | 2018 | 19 | 1.300 |
Why?
|
| Brain Neoplasms | 5 | 2017 | 638 | 1.220 |
Why?
|
| Tissue Distribution | 8 | 2024 | 61 | 1.130 |
Why?
|
| Administration, Intranasal | 1 | 2024 | 31 | 0.920 |
Why?
|
| Carbon Radioisotopes | 5 | 2019 | 24 | 0.870 |
Why?
|
| Animals | 21 | 2024 | 7541 | 0.860 |
Why?
|
| Microtubules | 2 | 2019 | 23 | 0.840 |
Why?
|
| Mice | 11 | 2022 | 2484 | 0.820 |
Why?
|
| Substance-Related Disorders | 2 | 2022 | 128 | 0.810 |
Why?
|
| Insulin | 1 | 2024 | 367 | 0.780 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 155 | 0.750 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 130 | 0.740 |
Why?
|
| Neovascularization, Pathologic | 2 | 2017 | 82 | 0.700 |
Why?
|
| Neoplasms | 4 | 2019 | 726 | 0.700 |
Why?
|
| Isotope Labeling | 4 | 2019 | 16 | 0.670 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 85 | 0.650 |
Why?
|
| Piperidines | 1 | 2019 | 118 | 0.640 |
Why?
|
| Receptors, Somatomedin | 1 | 2017 | 2 | 0.590 |
Why?
|
| Cell Line, Tumor | 8 | 2019 | 726 | 0.590 |
Why?
|
| Radioligand Assay | 1 | 2017 | 20 | 0.580 |
Why?
|
| Nicotine | 1 | 2019 | 171 | 0.580 |
Why?
|
| Benzopyrans | 1 | 2017 | 6 | 0.580 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2017 | 50 | 0.580 |
Why?
|
| Drug Delivery Systems | 2 | 2017 | 104 | 0.570 |
Why?
|
| Boron Compounds | 1 | 2017 | 11 | 0.570 |
Why?
|
| Neuroblastoma | 1 | 2017 | 31 | 0.560 |
Why?
|
| Pyrroles | 1 | 2017 | 55 | 0.560 |
Why?
|
| Pyrimidines | 1 | 2017 | 65 | 0.550 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 99 | 0.530 |
Why?
|
| Blood-Brain Barrier | 4 | 2019 | 48 | 0.500 |
Why?
|
| Ligands | 5 | 2022 | 81 | 0.500 |
Why?
|
| Methadyl Acetate | 1 | 2014 | 1 | 0.480 |
Why?
|
| Molecular Structure | 5 | 2019 | 59 | 0.450 |
Why?
|
| Tyrosine | 1 | 2013 | 23 | 0.440 |
Why?
|
| Alanine | 1 | 2013 | 27 | 0.440 |
Why?
|
| Triazoles | 1 | 2013 | 14 | 0.440 |
Why?
|
| Molecular Probes | 1 | 2013 | 16 | 0.430 |
Why?
|
| Butyrates | 1 | 2012 | 3 | 0.420 |
Why?
|
| Phenylurea Compounds | 1 | 2012 | 10 | 0.420 |
Why?
|
| Alpha Particles | 3 | 2017 | 7 | 0.420 |
Why?
|
| PPAR alpha | 1 | 2012 | 29 | 0.410 |
Why?
|
| Humans | 20 | 2022 | 32005 | 0.400 |
Why?
|
| Glioma | 1 | 2013 | 136 | 0.400 |
Why?
|
| Structure-Activity Relationship | 3 | 2019 | 80 | 0.350 |
Why?
|
| Male | 13 | 2024 | 19165 | 0.330 |
Why?
|
| Ketones | 1 | 2008 | 11 | 0.320 |
Why?
|
| Amides | 1 | 2008 | 18 | 0.320 |
Why?
|
| Mesylates | 1 | 2007 | 1 | 0.310 |
Why?
|
| Acetanilides | 1 | 2007 | 5 | 0.300 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 167 | 0.250 |
Why?
|
| Gallium Radioisotopes | 1 | 2024 | 2 | 0.230 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2024 | 3 | 0.230 |
Why?
|
| Heterocyclic Compounds | 1 | 2024 | 12 | 0.230 |
Why?
|
| Cations | 3 | 2008 | 10 | 0.230 |
Why?
|
| Rodentia | 1 | 2022 | 9 | 0.210 |
Why?
|
| Ascorbic Acid | 1 | 2022 | 23 | 0.210 |
Why?
|
| Doxorubicin | 1 | 2022 | 82 | 0.210 |
Why?
|
| Primates | 1 | 2022 | 108 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2022 | 633 | 0.200 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 157 | 0.200 |
Why?
|
| Receptors, Dopamine D3 | 2 | 2022 | 33 | 0.200 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2022 | 79 | 0.190 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2019 | 6 | 0.190 |
Why?
|
| Macaca | 1 | 2020 | 27 | 0.190 |
Why?
|
| Rats | 2 | 2022 | 1595 | 0.190 |
Why?
|
| Actinium | 2 | 2017 | 3 | 0.190 |
Why?
|
| Capillary Permeability | 2 | 2017 | 14 | 0.180 |
Why?
|
| Papio | 1 | 2020 | 91 | 0.180 |
Why?
|
| Neurotransmitter Agents | 1 | 2019 | 26 | 0.170 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2008 | 83 | 0.170 |
Why?
|
| Antibodies, Bispecific | 1 | 2019 | 6 | 0.170 |
Why?
|
| Diet, Mediterranean | 1 | 2019 | 31 | 0.170 |
Why?
|
| Cocaine | 1 | 2022 | 256 | 0.170 |
Why?
|
| Niacinamide | 1 | 2019 | 8 | 0.160 |
Why?
|
| Zirconium | 1 | 2018 | 2 | 0.160 |
Why?
|
| Radioisotopes | 1 | 2018 | 5 | 0.160 |
Why?
|
| Chlorides | 1 | 2018 | 13 | 0.160 |
Why?
|
| Immunoconjugates | 1 | 2018 | 9 | 0.160 |
Why?
|
| Tobacco Use Disorder | 1 | 2019 | 84 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2019 | 173 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 91 | 0.160 |
Why?
|
| Cyclization | 2 | 2008 | 2 | 0.160 |
Why?
|
| Argininosuccinate Synthase | 1 | 2018 | 2 | 0.160 |
Why?
|
| Electrochemistry | 2 | 2008 | 14 | 0.160 |
Why?
|
| Arginine | 1 | 2018 | 17 | 0.160 |
Why?
|
| Cell Proliferation | 3 | 2019 | 604 | 0.150 |
Why?
|
| Models, Biological | 2 | 2018 | 392 | 0.150 |
Why?
|
| Amino Acids | 1 | 2018 | 46 | 0.150 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2017 | 7 | 0.150 |
Why?
|
| Cell Differentiation | 2 | 2017 | 469 | 0.150 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2017 | 11 | 0.150 |
Why?
|
| Biological Transport | 1 | 2017 | 69 | 0.150 |
Why?
|
| Liposomes | 1 | 2017 | 27 | 0.150 |
Why?
|
| Urea | 1 | 2017 | 37 | 0.150 |
Why?
|
| Quinolines | 1 | 2017 | 21 | 0.150 |
Why?
|
| Sarcoma | 1 | 2018 | 73 | 0.140 |
Why?
|
| Substrate Specificity | 1 | 2017 | 87 | 0.140 |
Why?
|
| Molecular Imaging | 1 | 2017 | 20 | 0.140 |
Why?
|
| Ethylamines | 1 | 2016 | 2 | 0.140 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2016 | 2 | 0.140 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2016 | 3 | 0.140 |
Why?
|
| Cell Communication | 1 | 2017 | 32 | 0.140 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 58 | 0.140 |
Why?
|
| DNA Damage | 1 | 2017 | 98 | 0.140 |
Why?
|
| Protein Binding | 1 | 2017 | 201 | 0.140 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2016 | 23 | 0.140 |
Why?
|
| Peptide Fragments | 1 | 2019 | 399 | 0.140 |
Why?
|
| Pericytes | 1 | 2016 | 29 | 0.140 |
Why?
|
| Medical Oncology | 1 | 2017 | 86 | 0.130 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 264 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 327 | 0.130 |
Why?
|
| Female | 3 | 2024 | 19959 | 0.130 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 209 | 0.120 |
Why?
|
| Liver | 1 | 2017 | 484 | 0.110 |
Why?
|
| Cognition | 1 | 2017 | 555 | 0.110 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 26 | 0.110 |
Why?
|
| Metabolic Clearance Rate | 1 | 2013 | 17 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2013 | 81 | 0.110 |
Why?
|
| Obesity | 1 | 2020 | 1175 | 0.110 |
Why?
|
| Kidney | 1 | 2017 | 518 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 246 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 519 | 0.100 |
Why?
|
| Stereoisomerism | 2 | 2008 | 22 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 582 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 762 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 608 | 0.080 |
Why?
|
| Macaca mulatta | 2 | 2022 | 305 | 0.080 |
Why?
|
| Benzilates | 1 | 2008 | 2 | 0.080 |
Why?
|
| Mandelic Acids | 1 | 2008 | 2 | 0.080 |
Why?
|
| Hydroxylation | 1 | 2008 | 4 | 0.080 |
Why?
|
| Fluorenes | 1 | 2008 | 4 | 0.080 |
Why?
|
| Middle Aged | 2 | 2019 | 11817 | 0.080 |
Why?
|
| Indoles | 1 | 2008 | 56 | 0.080 |
Why?
|
| Models, Chemical | 1 | 2007 | 34 | 0.080 |
Why?
|
| Quinolones | 1 | 2007 | 7 | 0.080 |
Why?
|
| Reference Standards | 1 | 2007 | 32 | 0.080 |
Why?
|
| Salts | 1 | 2007 | 1 | 0.080 |
Why?
|
| Imines | 1 | 2007 | 2 | 0.080 |
Why?
|
| Electrons | 1 | 2007 | 12 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 918 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2017 | 115 | 0.070 |
Why?
|
| Adult | 1 | 2019 | 9345 | 0.070 |
Why?
|
| Self Administration | 1 | 2022 | 297 | 0.050 |
Why?
|
| Protein Transport | 1 | 2020 | 74 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 1328 | 0.050 |
Why?
|
| Eating | 1 | 2020 | 74 | 0.040 |
Why?
|
| Ethanol | 1 | 2022 | 187 | 0.040 |
Why?
|
| Ketone Bodies | 1 | 2019 | 8 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 95 | 0.040 |
Why?
|
| Radiochemistry | 1 | 2018 | 1 | 0.040 |
Why?
|
| Cyclosporine | 1 | 2019 | 49 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 93 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2019 | 81 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 321 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2019 | 107 | 0.040 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2018 | 1 | 0.040 |
Why?
|
| Hydrolases | 1 | 2018 | 5 | 0.040 |
Why?
|
| Cell Line | 1 | 2019 | 435 | 0.040 |
Why?
|
| Quinazolines | 1 | 2018 | 38 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 64 | 0.040 |
Why?
|
| Memory | 1 | 2019 | 190 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2018 | 96 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 545 | 0.040 |
Why?
|
| Cysteamine | 1 | 2017 | 2 | 0.040 |
Why?
|
| Copper Radioisotopes | 1 | 2017 | 3 | 0.040 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2017 | 17 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2017 | 41 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 62 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 215 | 0.040 |
Why?
|
| Peptides | 1 | 2017 | 120 | 0.030 |
Why?
|
| Antigens | 1 | 2016 | 31 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 743 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2016 | 32 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 71 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 81 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2017 | 178 | 0.030 |
Why?
|
| Cell Separation | 1 | 2016 | 92 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 338 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 110 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 291 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 169 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 632 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2014 | 101 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 767 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1022 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 2149 | 0.030 |
Why?
|
| Phenol | 1 | 2007 | 6 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 10301 | 0.020 |
Why?
|